GRTS - Gritstone Oncology - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

GRTS is currently covered by 4 analysts with an average price target of $1.62. This is a potential upside of $0.87 (116%) from yesterday's end of day stock price of $0.75.

Gritstone Oncology's activity chart (see below) currently has 4 price targets and 13 ratings on display. The stock rating distribution of GRTS is 90.91% BUY and 9.09% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.38% with an average time for these price targets to be met of 73.33 days.

Highest price target for GRTS is $7, Lowest price target is $6, average price target is $1.62.

Most recent stock forecast was given by MAYANK MAMTANI from B RILEY on 07-Dec-2023. First documented stock forecast 11-Dec-2018.

Best performing analysts who are covering GRTS - Gritstone Oncology:

Thomas Shrader Madhu Kumar Corinne Jenkins Sean Lee Edward Tenthoff Mayank Mamtani

Currently out of the existing stock ratings of GRTS, 10 are a BUY (90.91%), 1 are a SELL (9.09%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

6

$4.99 (494.06%)

8

4 months 17 days ago

0/2 (0%)

$4.38 (270.37%)

Buy

7

$5.99 (593.07%)

6

6 months 27 days ago

0/2 (0%)

$5.44 (348.72%)

Buy

7

$5.99 (593.07%)

7

8 months 14 days ago

1/7 (14.29%)

$5.18 (284.62%)

5

Sell

2

$0.99 (98.02%)

15

1 years 8 months 2 days ago

1/2 (50%)

$-1.74 (-46.52%)

267

Buy

35

2 years 6 months 9 days ago

0/2 (0%)

$9.45 (36.99%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GRTS (Gritstone Oncology) average time for price targets to be met?

On average it took 73.33 days on average for the stock forecasts to be realized with a an average price target met ratio 27.38

Which analyst has the current highest performing score on GRTS (Gritstone Oncology) with a proven track record?

THOMAS SHRADER

Which analyst has the current lower performing score on GRTS (Gritstone Oncology) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on GRTS (Gritstone Oncology)?

Thomas Shrader works at BTIG and has 10 price targets and 8 ratings on GRTS

Which analyst is the currently most bullish on GRTS (Gritstone Oncology)?

Edward Tenthoff with highest potential upside - $5.99

Which analyst is the currently most reserved on GRTS (Gritstone Oncology)?

Thomas Shrader with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?